2017
DOI: 10.1590/1678-4162-9460
|View full text |Cite
|
Sign up to set email alerts
|

Use of ractopamine during compensatory gain of finishing pigs on carcass and meat performance and quality

Abstract: The objective of this study was to evaluate the effects of compensatory gain associated with the use of 10ppm ractopamine after a period of feed restriction in finishing pigs on performance, carcass and meat quality. Twenty castrated males and 20 females, at 110 days of age and 66.137±6.13kg live weight, were submitted to four treatments using a 2 x 2 factorial design (fed ad libitum or with 20% restriction between 021 days of age and fed with or without 10ppm ractopamine for 2242 days of experimentation), w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
1
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 19 publications
0
1
0
1
Order By: Relevance
“…O atual estado da arte (2016-2022) apresenta poucos trabalhos (AMIN et al, 2017;BARBOSA et al, 2017;MORAES et al, 2020;SILVA et al, 2018) provenientes de estudos brasileiros que demonstraram a influência da RAC sobre o desenvolvimento do suíno antes do abate. Além disso, não foi encontrado nenhum trabalho de revisão que demonstrasse o aumento da produção de carne suína com o uso de RAC no rebanho para abate.…”
Section: Introductionunclassified
“…O atual estado da arte (2016-2022) apresenta poucos trabalhos (AMIN et al, 2017;BARBOSA et al, 2017;MORAES et al, 2020;SILVA et al, 2018) provenientes de estudos brasileiros que demonstraram a influência da RAC sobre o desenvolvimento do suíno antes do abate. Além disso, não foi encontrado nenhum trabalho de revisão que demonstrasse o aumento da produção de carne suína com o uso de RAC no rebanho para abate.…”
Section: Introductionunclassified
“…It has been proven that RAC can be retained in animals and subsequently enters the human body through the food chain, causing cumulative toxicity. Thus, when the accumulated RAC dose exceeds a certain level, toxic reactions, such as triggering muscle tremor, tachycardia, and muscle pain, may occur [ 6 , 7 , 8 ]. To avoid the potential risk of RAC to human health, many countries (including the USA, China and the European Union) and organizations have set strict regulations for RAC and other β-adrenergic agonists, with zero tolerance in animal feed or processing [ 9 , 10 ].…”
Section: Introductionmentioning
confidence: 99%